Skip to main content
. 2019 Apr;11(4):1145–1154. doi: 10.21037/jtd.2019.04.56

Table 2. The chemotherapy regimens (n=63).

Regimen LCNEC (n=31) SCLC (n=32)
Neoadjuvant setting (n=5)
   CDDP + CPT-11 0 1
   CDDP + VP-16 0 3
   CBDCA + VP-16 0 1
Adjuvant setting (n=58)
   CDDP + CPT-11 11 7
   CDDP + VP-16 6 14
   CBDCA + PTX 6 0
   CDDP + VNR 5 1
   CBDCA + VP-16 3 4
   CBDCA + CPT-11 0 1

CDDP, cisplatin; CPT-11, irinotecan; CBDCA, carboplatin; VNR, vinorelbine; PTX, paclitaxel; VP16, etoposide.